Related Experiment Video
Updated: Jun 13, 2026
09:09
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Antibacterial oxazolidinones: emerging structure-toxicity relationships
1Department of Pharmaceutical Chemistry and the Small Molecule Discovery Center, University of California, San Francisco, 1700 4th Street, San Francisco, CA 94158, USA. adam.renslo@ucsf.edu
Expert Review of Anti-Infective Therapy
|May 12, 2010
Summary
Oxazolidinones are antibiotics that inhibit bacterial protein synthesis. New research clarifies their toxicity mechanisms, like myelosuppression, and explores modifications to reduce side effects while maintaining antibacterial activity.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Microbiology
Background:
- Oxazolidinones are synthetic antibiotics crucial for combating Gram-positive and some Gram-negative bacterial infections.
- Key toxicities include reversible monoamine oxidase inhibition and myelosuppression, particularly with prolonged therapy.
Purpose of the Study:
- To elucidate the molecular mechanisms behind oxazolidinone-induced toxicities.
- To review structural modifications aimed at mitigating adverse effects while preserving antibacterial efficacy.
Main Methods:
- Review of recent toxicological studies.
- Analysis of structure-activity relationships for modified oxazolidinones.
Main Results:
- Identification of molecular pathways contributing to oxazolidinone-related myelosuppression and other toxicities.
- Demonstration that specific structural alterations can reduce toxicity without compromising antibacterial action.
Conclusions:
- Understanding the molecular basis of oxazolidinone toxicity is advancing.
- Structural optimization offers a promising strategy for developing safer and more effective oxazolidinone antibiotics.
Related Concept Videos
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...